Envoy Medical Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -65.0% | +2.5% | -20.6% | +39.5% | +22.8% | -10.0% | -4.7% | -17.4% | +4.6% | +248.5% | -19.7% | |
| – | -67.2% | +3.7% | -35.4% | +42.8% | +31.5% | -11.4% | -9.6% | -23.4% | +9.1% | +340.9% | -20.8% | |
| – | -43.3% | +17.2% | -64.7% | +153.4% | +23.9% | -3.1% | -0.5% | -32.7% | +5.1% | +575.3% | -22.1% | |
| – | -43.3% | +17.2% | -64.7% | +153.4% | +23.9% | -3.1% | -0.5% | -32.7% | +5.1% | +575.3% | -22.1% | |
| – | -93.7% | +215.7% | -8.6% | +13.4% | +257.2% | -94.9% | +50.0% | -44.4% | -2.9% | +41.2% | +37.5% | |
| – | +0.5% | +3.6% | +8.7% | +3.7% | +4.1% | -3.0% | -4.2% | +3.3% | -5.7% | -3.6% | +6.0% | |
| – | -42.1% | +58.2% | +20.3% | +46.0% | +8.8% | +13.9% | +14.9% | -60.5% | +29.4% | -5.2% | +7.1% | |
| – | -46.4% | -4.0% | +15.2% | +12.6% | -16.9% | +0.8% | +5.3% | +12.3% | +28.6% | +5.6% | +3.5% | |
| – | +6.0% | -0.6% | +11.5% | +28.6% | -36.4% | +1.4% | +36.6% | -15.2% | +3.6% | +2.3% | -25.8% | |
| – | -54.0% | -41.2% | +74.0% | +10.6% | -6.0% | +0.6% | -2.6% | +65.6% | +8.9% | -41.8% | +19.7% | |
| – | – | – | +51.3% | +96.9% | +30.4% | +23.5% | +20.9% | – | – | – | – | |
| – | -128.4% | – | – | – | – | – | – | – | – | – | -68.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | -5.1% | +5.4% | +0.1% | +8.7% | +0.0% | -8.1% | +11.5% | +111.0% | +49.5% | +50.9% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.